par Wohl, David;Cheret, Antoine;Brunetta, Jason;Mussini, Cristina;Tebas, Pablo;Sax, Paul Edward Dward P.E.;Cheng, Andrew K;Zhong, Lijie;Callebaut, Christian;Das, Moupali;Fordyce, Marshall;Oka, Shinichi;Friborg, Sandra;Villamejor, Kathleen;Huang, Jay;Guo, Susan;Liu, Hui;Wang, Hui;Miller, Michael;Margot, Nicolas;Clumeck, Nathan ;Clarke, Amanda;Brinson, Cynthia;Stephens, Jeffrey;Tashima, Karen;Arribas, Jose;Rashbaum, Bruce
Référence Journal of acquired immune deficiency syndromes, 72, 1, page (58-64)
Publication Publié, 2016-05
Référence Journal of acquired immune deficiency syndromes, 72, 1, page (58-64)
Publication Publié, 2016-05
Article révisé par les pairs
Titre: |
|
Auteur: | Wohl, David; Cheret, Antoine; Brunetta, Jason; Mussini, Cristina; Tebas, Pablo; Sax, Paul Edward Dward P.E.; Cheng, Andrew K; Zhong, Lijie; Callebaut, Christian; Das, Moupali; Fordyce, Marshall; Oka, Shinichi; Friborg, Sandra; Villamejor, Kathleen; Huang, Jay; Guo, Susan; Liu, Hui; Wang, Hui; Miller, Michael; Margot, Nicolas; Clumeck, Nathan; Clarke, Amanda; Brinson, Cynthia; Stephens, Jeffrey; Tashima, Karen; Arribas, Jose; Rashbaum, Bruce |
Informations sur la publication: | Journal of acquired immune deficiency syndromes, 72, 1, page (58-64) |
Statut de publication: | Publié, 2016-05 |
Sujet CREF: | Pharmacologie |
Pathologie maladies infectieuses | |
Mots-clés: | Bone mineral density |
HIV | |
Integrase inhibitor | |
Randomized controlled trial | |
Renal safety | |
Tenofovir alafenamide | |
Note générale: | SCOPUS: ar.j |
Langue: | Anglais |
Identificateurs: | urn:issn:1525-4135 |
info:doi/10.1097/QAI.0000000000000940 | |
info:scp/84973121361 | |
info:pmid/26829661 |